164 related articles for article (PubMed ID: 27390778)
1. Repurposing tromethamine as inhaled therapy to treat CF airway disease.
Abou Alaiwa MH; Launspach JL; Sheets KA; Rivera JA; Gansemer ND; Taft PJ; Thorne PS; Welsh MJ; Stoltz DA; Zabner J
JCI Insight; 2016 Jun; 1(8):. PubMed ID: 27390778
[TBL] [Abstract][Full Text] [Related]
2. Tromethamine improves mucociliary clearance in cystic fibrosis pigs.
Ash JJ; Hilkin BM; Gansemer ND; Hoffman EA; Zabner J; Stoltz DA; Abou Alaiwa MH
Physiol Rep; 2022 Sep; 10(17):e15340. PubMed ID: 36073059
[TBL] [Abstract][Full Text] [Related]
3. Acidic pH increases airway surface liquid viscosity in cystic fibrosis.
Tang XX; Ostedgaard LS; Hoegger MJ; Moninger TO; Karp PH; McMenimen JD; Choudhury B; Varki A; Stoltz DA; Welsh MJ
J Clin Invest; 2016 Mar; 126(3):879-91. PubMed ID: 26808501
[TBL] [Abstract][Full Text] [Related]
4. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung.
Pezzulo AA; Tang XX; Hoegger MJ; Abou Alaiwa MH; Ramachandran S; Moninger TO; Karp PH; Wohlford-Lenane CL; Haagsman HP; van Eijk M; Bánfi B; Horswill AR; Stoltz DA; McCray PB; Welsh MJ; Zabner J
Nature; 2012 Jul; 487(7405):109-13. PubMed ID: 22763554
[TBL] [Abstract][Full Text] [Related]
5. Effects of Tham Nasal Alkalinization on Airway Microbial Communities: A Pilot Study in Non-CF and CF Adults.
Holliday ZM; Launspach JL; Durairaj L; Singh PK; Zabner J; Stoltz DA
Ann Otol Rhinol Laryngol; 2022 Sep; 131(9):1013-1020. PubMed ID: 34674574
[TBL] [Abstract][Full Text] [Related]
6. Inflammation as a Regulator of the Airway Surface Liquid pH in Cystic Fibrosis.
Rehman T; Welsh MJ
Cells; 2023 Apr; 12(8):. PubMed ID: 37190013
[TBL] [Abstract][Full Text] [Related]
7. Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium.
Coakley RD; Grubb BR; Paradiso AM; Gatzy JT; Johnson LG; Kreda SM; O'Neal WK; Boucher RC
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):16083-8. PubMed ID: 14668433
[TBL] [Abstract][Full Text] [Related]
8. Esomeprazole Increases Airway Surface Liquid pH in Primary Cystic Fibrosis Epithelial Cells.
Delpiano L; Thomas JJ; Yates AR; Rice SJ; Gray MA; Saint-Criq V
Front Pharmacol; 2018; 9():1462. PubMed ID: 30618754
[TBL] [Abstract][Full Text] [Related]
9. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.
Haq IJ; Gray MA; Garnett JP; Ward C; Brodlie M
Thorax; 2016 Mar; 71(3):284-7. PubMed ID: 26719229
[TBL] [Abstract][Full Text] [Related]
10. Evidence for airway surface dehydration as the initiating event in CF airway disease.
Boucher RC
J Intern Med; 2007 Jan; 261(1):5-16. PubMed ID: 17222164
[TBL] [Abstract][Full Text] [Related]
11. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
Moore PJ; Tarran R
Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216
[TBL] [Abstract][Full Text] [Related]
12. Glandular Proteome Identifies Antiprotease Cystatin C as a Critical Modulator of Airway Hydration and Clearance.
Evans TI; Joo NS; Keiser NW; Yan Z; Tyler SR; Xie W; Zhang Y; Hsiao JJ; Cho HJ; Wright ME; Wine JJ; Engelhardt JF
Am J Respir Cell Mol Biol; 2016 Apr; 54(4):469-81. PubMed ID: 26334941
[TBL] [Abstract][Full Text] [Related]
13. Extracellular pH and lung infections in cystic fibrosis.
Massip-Copiz MM; Santa-Coloma TA
Eur J Cell Biol; 2018 Aug; 97(6):402-410. PubMed ID: 29933921
[TBL] [Abstract][Full Text] [Related]
14. Measuring airway surface liquid depth in ex vivo mouse airways by x-ray imaging for the assessment of cystic fibrosis airway therapies.
Morgan KS; Donnelley M; Paganin DM; Fouras A; Yagi N; Suzuki Y; Takeuchi A; Uesugi K; Boucher RC; Parsons DW; Siu KK
PLoS One; 2013; 8(1):e55822. PubMed ID: 23383288
[TBL] [Abstract][Full Text] [Related]
15. Airway acidification initiates host defense abnormalities in cystic fibrosis mice.
Shah VS; Meyerholz DK; Tang XX; Reznikov L; Abou Alaiwa M; Ernst SE; Karp PH; Wohlford-Lenane CL; Heilmann KP; Leidinger MR; Allen PD; Zabner J; McCray PB; Ostedgaard LS; Stoltz DA; Randak CO; Welsh MJ
Science; 2016 Jan; 351(6272):503-7. PubMed ID: 26823428
[TBL] [Abstract][Full Text] [Related]
16. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy.
Boucher RC
Annu Rev Med; 2007; 58():157-70. PubMed ID: 17217330
[TBL] [Abstract][Full Text] [Related]
17. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
Tarran R; Donaldson S; Boucher RC
Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
[TBL] [Abstract][Full Text] [Related]
18. Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator.
Poulsen JH; Fischer H; Illek B; Machen TE
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5340-4. PubMed ID: 7515498
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Protease-Epithelial Sodium Channel Signaling Improves Mucociliary Function in Cystic Fibrosis Airways.
Reihill JA; Walker B; Hamilton RA; Ferguson TE; Elborn JS; Stutts MJ; Harvey BJ; Saint-Criq V; Hendrick SM; Martin SL
Am J Respir Crit Care Med; 2016 Sep; 194(6):701-10. PubMed ID: 27014936
[TBL] [Abstract][Full Text] [Related]
20. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
Mall MA
Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
